NuVasive to Present at Thomas Weisel Partners Healthcare ...(Group NuVasive Inc. ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Date:8/22/2007
Group
NuVasive, Inc. 646-536-7030/7020
858-909-1800 nlaudico@theruthgroup.com
investorrelations@nuvasive.com zkubow@theruthgroup.com
Media:
Jason Rando
The Ruth Group
646-536-7025
'/>"/>
| SOURCE NuVasive, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3
[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head[0] Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors[0] Quest Diagnostics Declares Quarterly Cash Dividend[0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease
Other Biology Technology:Women's entrepreneurial event set for May 21 2Motorcycling entrepreneur to speak in Madison on success, failure, capital 2Motorcycling entrepreneur to speak in Madison on success, failure, capital 3Wisconsin fares slightly better in venture capital chase 2Wisconsin fares slightly better in venture capital chase 3
Breaking Biology News(10 mins):Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3IGC scientist receives prestigious EMBO installation grant 2Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3Found 3A A gene that may play a role in type 1 diabetes 54083 1Found 3A A gene that may play a role in type 1 diabetes 54083 2Taking the needles sting out of diabetes 54078 1Taking the needles sting out of diabetes 54078 2Fountain of Life Group Debuts VaNu at the Pro Football Hall of Fame Enshrinement Weekend 54074 1Fountain of Life Group Debuts VaNu at the Pro Football Hall of Fame Enshrinement Weekend 54074 2
Other Biology News:Prions rapidly 'remodel' good protein into bad, Brown study shows 2Emerald Spectre haunts Ontario's ash forests 2Emerald Spectre haunts Ontario's ash forests 3Research team receives $7.5 million to study cassava 2
Biology Products:
Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscienceGoat Anti-VAV2 Antibody, Unconjugated from Raybiotech, Inc.Rabbit Anti-M13 Bacteriophage Coat Proteins Polyclonal Antibody, Unconjugated from AbcamRabbit Anti-E2F-5 Polyclonal Antibody, Unconjugated from Spring Bioscience
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |